Sign Up for Bullseye Daily Alerts
Subscribe to our newsletter to get our newest articles instantly!
I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…
AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming entire fields. From virtual…
Microsoft (MSFT) is the chill tech uncle you secretly admire, vibing at $393.08 (MacroTrends) as of…
Nvidia (NVDA) is the electrifying frontman of the tech scene, rocking the AI and semiconductor stage…
Welcome to the biotech jungle, where the vines are thick, the stakes are high, and the…
I’ve always been fascinated by space… I grew up on Dune, 2001:…
Retail investors crushed it in April 2025 — buying when hedge funds…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt…
Consumers Are Scared, and That Means — Opportunity! The headlines have been…
Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…
BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…
Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…
Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market cap north of $125…
Sign in to your account